Cholesterol-Lowering Intervention Decreases mTOR Complex 2 Signaling and Enhances Antitumor Immunity

Abstract

Lowering serum cholesterol decreased signaling through mTORC2 and enhanced antitumor CD8⁺ T-cell memory. We provide a rationale for large-scale clinical testing of cholesterol lowering strategies for prostate cancer chemoprevention.